Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.21 - $0.32 $3,321 - $5,061
15,817 Added 23.5%
83,123 $19,000
Q2 2022

Aug 11, 2022

BUY
$0.26 - $0.64 $1,848 - $4,551
7,111 Added 11.81%
67,306 $28,000
Q1 2022

May 12, 2022

SELL
$0.52 - $1.0 $471 - $906
-906 Reduced 1.48%
60,195 $36,000
Q4 2021

Feb 11, 2022

SELL
$0.85 - $1.33 $2,003 - $3,134
-2,357 Reduced 3.71%
61,101 $59,000
Q3 2021

Nov 12, 2021

BUY
$1.03 - $1.41 $53,359 - $73,045
51,805 Added 444.56%
63,458 $86,000
Q2 2021

Aug 12, 2021

BUY
$1.04 - $1.5 $12,119 - $17,479
11,653 New
11,653 $13,000

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.